Age standardized mortality rates (SMR) 
INTRODUCTION
As medical techniques and care have developed, there has been increasing concern over how the quality and outcome of medical care can be measured. Concern with the measurement of such quality has often focussed on the work of Donabedian (see, e.g., [1] ), who was one of the principle early investigators of this problem. He assessed the quality of health care in terms of its structure and process, and its outcome.
Much of the work developing from these ideas focussed on the structure and process of health care, and did not focus sufficient attention on its outcome. Commonly, health services were compared against some 'norms' which were seen as acceptable standards. This approach did not show how the outcome of a health intervention could be measured, and Donabedian emphasised the difficulties associated with such measures.
However, in the 1970s, the concept of 'Avoidable Mortality' grew from the work of the Working Group on Preventable and Manageable Diseases in the US [2] . Rutstein [2] studied morbidity and mortality as a measure of outcome. He and his colleagues identified a number of 'negative' events which could be regarded as indicators of the standard of health care. Rutstein's work counted cases of 'unnecessary' disability and untimely deaths from certain conditions which could be avoided given appropriate and timely medical interventions.
These so-called indicators can be divided into two groups: sentinel events, i.e. a specific incident which causes concern, for example a death from smallpox, or a death following appendicitis surgery in a young person [3] ; the second group consists of mortality rates in an area for a variety of conditions, for example, deaths from stroke.
The list of conditions from which death, in certain circumstances could be deemed 'avoidable' was extensive and covered diseases such as botulism and cholera; covered failures of preventive activities (for example failures of policy preventing exposure to asbestos) and also concluded that deaths from certain conditions were avoidable given current standards of medical care. Comparisons across geographic area were made, as opposed to the comparison of hospital mortality rates [4] . These studies examined the variability of mortality of patients treated within a hospital. However, variations in case mix are not taken into account, nor are the existence of certain 'centres of excellence' for conditions, which might result in their attracting the more complex cases. Obviously, this methodology is inadequate for the measurement of quality of health care.
In the early 1980s, the work on avoidable deaths was developed further by Charlton et al. in the UK [5\. They examined 14 conditions from Rutstein's list on which there was relative unanimity that appropriate and timely medical intervention could prevent mortality, and they therefore concluded that death rates from these conditions indicated some level of the quality of health care. Charlton and Holland published the results of this work, initially for England and Wales. The results indicated large variations in mortality for 10 of the conditions. The exercise was repeated but these large variations persisted over time, so could not be regarded as random variation [6] . Tables 1-3 illustrate the variation that existed, and which has been shown to have persisted over time. Charlton et al. were aware of the frequently voiced criticism that such variations were often due to social and other variables. Table 4 gives examples of these possible components of differences in avoidable mortality.
However, when the results of the work were correlated against a number of social variables the differences persisted-it was evident that social variables could not account for such variation. Additionally differences due to age and sex could be corrected using simple standardization techniques.
Following this work, in 1983, an EC Working Party was set up to develop this work further in Europe, and enable comparisons within and between the participating countries [7] . Within the UK, variations for same conditions were six-fold; within the entire EC differences of ten-fold and greater were identified.
The conditions used in this, most recent, work were chosen specifically because they illustrate a number of aspects of health-care provision: primary, secondary and preventive (Table 5) .
Before this work was developed, there were no measures of outcome included in the Department of Health performance indicators. As the work on avoidable mortality became more sophisticated, they were included in some refinements of Obviously, despite the evident usefulness of this measure of quality, and the previous paucity of work in this area, there has been a number of criticisms levelled at this method of assessing outcome, which ought to be addressed.
The current European Community work [7] (and earlier work by Churlton et al. [5] ) covers only specific conditions from which deaths within certain age groups are deemed 'avoidable'.
However, variations in mortality from these conditions could be due to a number of factors; it has been suggested that variations in avoidable mortality could be due to variation in incidence or case fatality (although ideally, health services should respond to changed incidence), differing certification or coding practices or to differing provision of services or resources. This criticism is valid and provides a warning of the consequences of misuse of avoidable mortality measures. This work is meant to direct attention to areas of concern, not make definitive statements of their causes. For example, in the case of cervical cancer, widely varying mortality between areas can often be explained by social class factors. . However, this explanation should not deflect concern for this conditionobviously a failure of screening or education may be identified as a contributor to such variation-and the problem can be addressed.
A further criticism is that often, in the work so far, the numbers of deaths have been rather small-and worries of their representativeness have been voiced. This is a fair criticism if a comparison of mortality rates is required. If the use of 'sentinel events' is accepted, however, even small numbers of deaths are valid pointers for areas of concern. Also, even small numbers of deaths, if present over time, are worthy of concern. Obviously, however, there is always the risk of artefactual variation in the data.
Despite the criticisms, avoidable mortality is now considered by many as a useful measure of quality.
Such measures are effective in promoting concern with high mortality rates. This has resulted in a number of confidential inquiries into specific deaths, the reports of which have been widely publicised.
Confidential enquiries of maternal mortality have been carried out for many years and provide a good example of the effectiveness of this approach. Recommendations stemming from these have been implemented and there have been dramatic improvements in maternal mortality often attributed to this form of enquiry.
Similar methods are now being used to investigate other 'avoidable' deaths-for example perinatal deaths. Once again, in some areas under enquiry, there has been a fall in the death rates. However, the reasons for this are difficult to identify.
In some cases, confidential enquiries have been able to identify a specific health service failure.
CERVICAL CANCER
In two districts in the UK, high rates for mortality from carcinoma of the cervix were observed. On further investigation it became apparent that they were due to very different problems: in one area of failure of the screening process to reach high risk individuals-in the other a failure of the screening process to follow up abnormalities. Thus, the problems could be tackled in the most appropriate manner.
CEREBROVASCULAR AND HYPERTENSIVE DISEASE
An investigation of deaths from cerebrovascular and hypertensive disease identified a failure of follow-up treatment.
ASTHMA
Investigations of asthma deaths have not identified any differences in treatment which could account for the rates. It seems likely that there is widely varying incidence, between areas, the reasons for which need further investigation [9] .
Avoidable death provides a valuable measure of quality. Its use has far reaching implications, not only for health policy, but also for other aspects of government policy (road safety policies for deaths from motor vehicle accidents; policy on smoking and sale of tobacco on deaths from cancer of the lung; policies on the sale of alcohol on deaths from cirrhosis of the liver). It has a valuable part to play in observing changes in performance over time. The methodology can be applicable to other areas of concern, for example alerting managers to variations in mortality within regions. Figure 1 gives an example of the sort of variation that can exist, using mortality for hip replacements.
This technique can provide indicators of areas where further research is necessary. For example in the UK a number of more detailed studies are currently under way. Deaths from stroke are being examined using stroke registers in three areas in Southern England; deaths from bladder cancer are being examined in an effort to see whether variations in mortality are related to the stage at which the disease is diagnosed; variations in asthma deaths are being examined in a large international study; and variations in deaths from fractured neck of femur are also being examined in an effort to identify any variations in care that may exist.
